Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EPS (Basic)EPS (Weighted Average and Diluted)Interest & Investment IncomeInterest ExpensesInterest ExpensesNon Operating IncomeOperating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Nautilus Biotechnology (NAUT) Shares Outstanding (Diluted Average) (2020 - 2026)

Nautilus Biotechnology has reported Shares Outstanding (Diluted Average) over the past 7 years, most recently at $126.6 million for Q1 2026.

  • Quarterly results put Shares Outstanding (Diluted Average) at $126.6 million for Q1 2026, changed 0.39% from a year ago — trailing twelve months through Mar 2026 was $126.6 million (changed 0.39% YoY), and the annual figure for FY2025 was $126.3 million, up 0.66%.
  • Shares Outstanding (Diluted Average) reached $126.6 million in Q1 2026 per NAUT's latest filing, roughly flat from $126.3 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $126.6 million in Q1 2026 and bottomed at $124.4 million in Q1 2022.
  • Median Shares Outstanding (Diluted Average) over the past 5 years was $125.1 million (2024), compared with a mean of $125.3 million.
  • The largest annual shift saw Shares Outstanding (Diluted Average) skyrocketed 277.03% in 2022 before it increased 0.09% in 2023.
  • Over 5 years, Shares Outstanding (Diluted Average) stood at $124.6 million in 2022, then rose by 0.26% to $124.9 million in 2023, then grew by 0.41% to $125.4 million in 2024, then rose by 0.66% to $126.3 million in 2025, then rose by 0.3% to $126.6 million in 2026.
  • Business Quant data shows Shares Outstanding (Diluted Average) for NAUT at $126.6 million in Q1 2026, $126.3 million in Q4 2025, and $126.2 million in Q3 2025.